Neurology Unit, Spedali Civili of Brescia, Brescia.
Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Eur J Neurol. 2020 Feb;27(2):265-272. doi: 10.1111/ene.14071. Epub 2019 Sep 18.
Behavioural disturbances are the core features of frontotemporal dementia (FTD); however, symptom progression is still not well characterized during the entire course of the disease. The aim of the present study was to investigate behavioural symptoms at baseline and during the disease course in a large cohort of patients with behavioural variant FTD (bvFTD), non-fluent/agrammatic variant primary progressive aphasia (nfvPPA) and semantic variant primary progressive aphasia (PPA).
We evaluated 403 patients with FTD, 167 of whom had at least 1-year follow-up evaluation (for a total of 764 assessments). Behavioural symptoms were assessed and rated through the Neuropsychiatric Inventory (NPI) and Frontal Behavioural Inventory (FBI). Disease severity was evaluated through the Frontotemporal Lobar Degeneration -Clinical Dementia Rating scale (FTLD-CDR). Linear mixed models were used to model behavioural measures (NPI, FBI and the five FBI-behavioural core criteria scores) as a function of disease severity (FTLD-CDR score) and clinical phenotype.
At baseline, patients with bvFTD showed more behavioural disturbances compared with those with nfvPPA (P = 0.004). Negative symptoms (apathy and loss of empathy) showed a trend to an increase throughout the course of the disease in both bvFTD and PPA (P < 0.001 until intermediate stages). Positive symptoms (disinhibition, perseverations and hyperorality) increased until intermediate phases (P < 0.001) followed by a progressive reduction in later phases, whereas they were less common in nfvPPA throughout the disease course.
We demonstrated that behavioural disturbances differed in FTD and with disease severity. Positive symptoms appeared to improve in the advanced stages, highlighting the importance of taking into account the disease severity as outcome measure in clinical trials.
行为障碍是额颞叶痴呆(FTD)的核心特征;然而,疾病的整个过程中,症状的进展仍未得到很好的描述。本研究的目的是在一个大的行为变异型额颞叶痴呆(bvFTD)、非流利/语法障碍原发性进行性失语(nfvPPA)和语义变异型原发性进行性失语(PPA)患者队列中,研究基线和疾病过程中的行为症状。
我们评估了 403 名 FTD 患者,其中 167 名患者至少有 1 年的随访评估(共 764 次评估)。通过神经精神问卷(NPI)和额叶行为量表(FBI)评估行为症状,并进行评分。通过额颞叶变性 -临床痴呆评定量表(FTLD-CDR)评估疾病严重程度。线性混合模型用于将行为测量(NPI、FBI 和 FBI 五个行为核心标准评分)作为疾病严重程度(FTLD-CDR 评分)和临床表型的函数进行建模。
基线时,与 nfvPPA 相比,bvFTD 患者的行为障碍更严重(P=0.004)。在 bvFTD 和 PPA 中,负性症状(淡漠和同理心丧失)在整个疾病过程中都呈增加趋势(P<0.001,直至中期)。阳性症状(脱抑制、固着和过度口欲)在中期增加(P<0.001),然后在后期逐渐减少,而在整个疾病过程中,nfvPPA 中阳性症状较少。
我们证明了 FTD 中的行为障碍存在差异,且与疾病严重程度有关。阳性症状在晚期似乎有所改善,这突出了在临床试验中考虑疾病严重程度作为结果衡量指标的重要性。